2024 Inspector Training @ ISCT Vancouver FACILITATOR ONLY REGISTRATION
FACT's inspector training course will be held on May 28, 2024, in conjunction with the International Society for Cell & Gene Therapy (ISCT) Conference in Vancouver, BC, held May 29 - June 1, 2024, at the Vancouver Convention Centre, West Building. Connecting with global experts from academic, regulatory, and industry in the cell and gene therapy field. Earn AMA PRA Category 1 Credit™ for attending! Inspector trainees and Inspectors can register today for this great training event.
|
|
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Illinois State Medical Society (ISMS) through the joint providership of Edward-Elmhurst Health and FACT. Edward-Elmhurst Health is accredited by the ISMS to provide continuing medical education for physicians. This live activity is designated for a maximum of 8.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
Phyllis I. Warkentin, MD
Chief Medical Officer
FACT
Dr. Phyllis Warkentin is a founding member of the Foundation for the Accreditation of Cellular Therapy (FACT), a member of the FACT Board of Directors, and the FACT Chief Medical Officer. She is a Pathology, Microbiology, Immunology, and Pediatrics professor at the University of Nebraska Medical Center, Omaha, NE, and the Medical Director of the Nebraska Medicine Blood and Marrow Transplant Marrow Collection Program. She has authored over one hundred scientific publications in transfusion, transplantation, and cellular therapy. She is a graduate of the University of Minnesota Medical School, Minneapolis, MN, board certified in pediatric hematology/oncology and transfusion medicine.
No Disclosures
Joseph Schwartz, MD, MPH
Senior Medical Officer
FACT
Joseph Schwartz, MD, MPH
Dr. Schwartz received his MD from the Technion – Israel Institute of Technology and his MPH from Columbia University Mailman School of Public Health. Upon completion of his training, he pursued a decades-long career in promoting excellence in the field of Transfusion Medicine, Apheresis & Cellular Therapy across a multitude of facilities including Columbia University Irving Medical Center, Moffitt Cancer Center and joined the Foundation for the Accreditation of Cellular Therapy (FACT) as their Senior Medical Officer and was appointed as Chief Medical Officer beginning January 2027. In these capacities, he brought many years of leadership experience directing Transfusion Medicine, Apheresis & Cellular Therapy Services. Throughout his tenure in the field, Dr. Schwartz became an active member of the professional and academic community. He had been involved in many professional organizations including AABB, CAP, ISCT, and ASCP as well as many leadership positions, including chairing Lab Practice Committees. He served as the president of ASFA in 2018-2019 and is currently the Immediate Past-President of the World Apheresis Association. He is currently a scientific member of BEST – the premier research organization for Transfusion Medicine and Cellular Therapies. He served on the writing committee of ASFA’s Therapeutic Apheresis guidelines for five editions. Furthermore, he promoted quality and standardization through dissemination of the FACT-JACIE international standards for cellular therapy. For these efforts and many more, he earned many honors including the AABB Hemphill Jordan Leadership Award (2019), ASFA’s Presidential Award (2021), ASFA’s Francis Morrison lectureship Award (2023), and ASFA’s Lecturer award (2024).
No Disclosures.
![]() |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Illinois State Medical Society (ISMS) through the joint providership of Edward-Elmhurst Health and FACT. Edward-Elmhurst Health is accredited by ISMS to provide continuing medical education for physicians. This live activity is designated for a maximum of 8.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
